Suppr超能文献

胃肠道癌症中的p53与微小RNA的联系

The p53/microRNA connection in gastrointestinal cancer.

作者信息

Rokavec Matjaz, Li Huihui, Jiang Longchang, Hermeking Heiko

机构信息

Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.

出版信息

Clin Exp Gastroenterol. 2014 Sep 30;7:395-413. doi: 10.2147/CEG.S43738. eCollection 2014.

Abstract

The protein encoded by the TP53 gene is one of the most important suppressors of tumor formation, which is also frequently inactivated in gastrointestinal cancer. MicroRNAs (miRNAs) are small noncoding RNAs that inhibit translation and/or promote degradation of their target messenger RNAs. In recent years, several miRNAs have been identified as mediators and regulators of p53's tumor suppressing functions. p53 induces expression and/or maturation of several miRNAs, which leads to the repression of critical effector proteins. Furthermore, certain miRNAs regulate the expression and activity of p53 through direct repression of p53 or its regulators. Experimental findings indicate that miRNAs are important components of the p53 network. In addition, the frequent genetic and epigenetic alterations of p53-regulated miRNAs in tumors indicate that they play an important role in cancer initiation and/or progression. Therefore, p53-regulated miRNAs may represent attractive diagnostic and/or prognostic biomarkers. Moreover, restoration of p53-induced miRNAs results in suppression of tumor growth and metastasis in mouse models of cancer. Thus, miRNA-based therapeutics may represent a feasible strategy for future cancer treatment. Here we summarize the current published state-of-the-art on the role of the p53-miRNA connection in gastrointestinal cancer.

摘要

TP53基因编码的蛋白质是肿瘤形成最重要的抑制因子之一,在胃肠道癌中也经常失活。微小RNA(miRNA)是小的非编码RNA,可抑制其靶信使RNA的翻译和/或促进其降解。近年来,几种miRNA已被鉴定为p53肿瘤抑制功能的介质和调节剂。p53诱导几种miRNA的表达和/或成熟,从而导致关键效应蛋白的抑制。此外,某些miRNA通过直接抑制p53或其调节剂来调节p53的表达和活性。实验结果表明,miRNA是p53网络的重要组成部分。此外,肿瘤中p53调节的miRNA频繁的基因和表观遗传改变表明它们在癌症发生和/或进展中起重要作用。因此,p53调节的miRNA可能是有吸引力的诊断和/或预后生物标志物。此外,在癌症小鼠模型中,恢复p53诱导的miRNA可导致肿瘤生长和转移受到抑制。因此,基于miRNA的治疗可能是未来癌症治疗的一种可行策略。在此,我们总结了目前已发表的关于p53-miRNA联系在胃肠道癌中作用的最新研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/191c/4198153/5c77dc731fc1/ceg-7-395Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验